TECHNOLOGY AND CODE article
Front. Bioinform.
Sec. Single Cell Bioinformatics
Volume 5 - 2025 | doi: 10.3389/fbinf.2025.1641491
TCRscape: A Single-Cell Multi-Omic TCR Profiling Toolkit
Provisionally accepted- Research Institute for Fundamental and Clinical Immunology (NIIFKI), Novosibirsk, Russia
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Introduction. Single-cell multi-omics has transformed T-cell biology by enabling the simultaneous analysis of T-cell receptor (TCR) sequences, transcriptomes, and surface proteins at the resolution of individual cells. These capabilities are critical for identifying antigen-specific T-cells and accelerating the development of TCR-based immunotherapies. Methods. Here, we introduce TCRscape, an open-source Python 3 tool designed for high-resolution T-cell receptor clonotype discovery and quantification, optimized for BD Rhapsody™ single-cell multi-omics data. Results. TCRscape integrates full-length TCR sequence data with gene expression profiles and surface protein expression to enable multimodal clustering of αβ and γδ T-cell populations. It also outputs Seuratcompatible matrices, facilitating downstream visualization and analysis in standard single-cell analysis environments. Discussion. By bridging clonotype detection with immune cell transcriptome, proteome, and antigen specificity profiling, TCRscape supports rapid identification of dominant T-cell clones and their functional phenotypes, offering a powerful resource for immune monitoring and TCRengineered therapeutic development. TCRscape can be found at https://github.com/Perik-Zavodskii/TCRscape/.
Keywords: ScRNA-seq, scTCR-seq, tcr, T-cell receptor, Clonotype, CDR3, TCR T-cells
Received: 05 Jun 2025; Accepted: 25 Aug 2025.
Copyright: © 2025 Perik-Zavodskii, Perik-Zavodskaia, Volynets, Alrhmoun and Sennikov. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Roman Perik-Zavodskii, Research Institute for Fundamental and Clinical Immunology (NIIFKI), Novosibirsk, Russia
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.